✦ LIBER ✦

Maraviroc makes a difference for R5 HIV-1 infections

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maraviroc approved in the US for HIV-1 i

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Efficacy of short-term monotherapy with

✍ Fätkenheuer, Gerd; Pozniak, Anton L; Johnson, Margaret A; Plettenberg, Andreas; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB

Prevalence of R5 strains in multi-treate

✍ Bon, Isabella; Clò, Alberto; Borderi, Marco; Colangeli, Vincenzo; Calza, Leonard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 525 KB

Cost-effectiveness of optimized backgrou

✍ Santiago Moreno; Juan González; Ingrid Lekander; Belén Martí; Itziar Oyagüez; Ra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 157 KB

HIV-1 infection in a man homozygous for

✍ Thomas R O'Brien; Cheryl Winkler; Michael Dean; Julie AE Nelson; Mary Carrington 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 20 KB

The magnitude of HIV-1 resistance to the

✍ Flynn, Jacqueline K.; Paukovics, Geza; Moore, Miranda S.; Ellett, Anne; Gray, La 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 988 KB